Previous 10 | Next 10 |
Nutra Pharma is providing comments on the SEC Complaint filed against Nutra Pharma, its CEO and a Consultant to the company. CORAL SPRINGS, Fla., Sept. 28, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC: NPHC), provided the following comment on the lawsuit fi...
CORAL SPRINGS, Fla., Sept. 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin ® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that their wo...
Nutra Pharma is announcing its agreement with an Internet marketing firm for their Over-the-Counter Pain Remedies: Nyloxin® and Pet Pain-Away™ CORAL SPRINGS, Fla., July 17, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Nutra Pharma Corporation (OTC:NPHC), a biotechnology com...
Nutra Pharma is announcing the next phase of marketing their Over-the-Counter (OTC) pain reliever for dogs and cats, Pet Pain-Away ™ through their direct response partner, DEG Productions CORAL SPRINGS, Fla., July 03, 2018 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC:NPH...
Nutra Pharma is announcing the execution of a Letter of Intent for a $4 Million financing to fund a joint venture for the marketing and distribution of the Company’s Over-the-Counter products. CORAL SPRINGS, Fla., June 28, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharm...
Nutra Pharma is announcing the next phase of marketing their Over-the-Counter (OTC) pain reliever for dogs and cats, Pet Pain-Away ™ through their direct response partner, DEG Productions. CORAL SPRINGS, Fla., June 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pha...
CORAL SPRINGS, Fla., April 19, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that they have partnered...
CORAL SPRINGS, Fla., April 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin ® and Pet Pain-Away ™ in the over-the-counter (OTC) pain management market, and which is also developing treatments fo...
CORAL SPRINGS, Fla., March 08, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company developing drugs for the treatment of Multiple Sclerosis (MS) and HIV and that also markets the over-the-counter (OTC) pain drugs; Nyloxin® and ...
CORAL SPRINGS, Fla., Feb. 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Nutra Pharma Corporation (OTC:NPHC), a biotechnology company marketing Nyloxin ® and Pet Pain-Away ™ in the over-the-counter (OTC) pain management market, and which is also developing treatments fo...
News, Short Squeeze, Breakout and More Instantly...
CORAL SPRINGS, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC:NPHC), ("Nutra Pharma" or the "Company") reached a settlem...
CORAL SPRINGS, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S. Securities and Exchange Commission (“SEC”) earlier this week. On March 19, 2024, t...
Odyssey Marine Exploration Inc. (OMEX) is expected to report for quarter end 2023-06-30 The Very Good Food Company Inc. (VGFCQ) is expected to report for quarter end 2023-06-30 SeaChange International Inc. (SEAC) is expected to report for Q1 2024 Allena Pharmaceuticals Inc. (ALNAQ) is...